Ebronucimab (Anti-PCSK9)

Ebronucimab (Anti-PCSK9) is a fully human immunoglobulin G1 (IgG1) monoclonal antibody against proprotein convertase subtilisin/kexin type 9 (PCSK9) used to treat hyperlipidemia. MW : 144.76 KD.
Supplier Selleck Chemicals
Product # A2843
Sku # A2843-1mg*5
Pricing 1mg*5, $1690.00
Feedback